NCT06182189

Brief Summary

Prospective observational study on the quality of life of patients with BPH under medical therapy and/or undergoing surgery.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
8,000

participants targeted

Target at P75+ for all trials

Timeline
106mo left

Started Dec 2014

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress57%
Dec 2014Dec 2034

Study Start

First participant enrolled

December 1, 2014

Completed
9 years until next milestone

First Submitted

Initial submission to the registry

November 21, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

December 26, 2023

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
10 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2034

Expected
Last Updated

December 26, 2023

Status Verified

December 1, 2023

Enrollment Period

10.1 years

First QC Date

November 21, 2023

Last Update Submit

December 21, 2023

Conditions

Keywords

benign prostatic hyperplasia; urology

Outcome Measures

Primary Outcomes (9)

  • Medical history

    \- patient's medical history, past surgical history, family medical history, social history, allergies, medications;

    Baseline

  • Psycho-behavioural data - male sexual health

    Male sexual health assessed through the Questionnaire for the evaluation of male sexual health" MSHQ(25-item, range: 7 - 80, greater score indicating better function,

    Baseline and up to 6 months

  • Physical examination - Body temperature

    Body temperature detection (Celsius degree)

    Baseline

  • Psycho-behavioural data - erectile function

    Erectile function assessed through the "International Index of Erectile Function" questionnaire IIEF (scoring: 1 - 30 - 6-10: severe; 11-16: Moderate; 17-25: mild; 26-30: absence

    Baseline and up to 6 months

  • Prostatic Symptoms

    Prostatic Symptoms assessed through the IPSS questionnaire, International Prostatic Symptoms Score: , Scoring 0 -7, 0-7 mild symptoms, 8-19 moderate symptoms, 20-35 severe symptoms;

    Baseline and up to 6 months

  • Incontinence Symptoms

    Incontinence Symptoms assessed through the ICIQ - International Consultation of Incontinence Questionnaire, ICIQ-SF has a maximum score of 21; the higher the score, the more severe is the UI, but there is no normal score;

    Baseline and up to 6 months

  • Physical examination - Body temperature pulse rate

    Pulse rate detection (beats per minute)

    Baseline

  • Physical examination - respiration assessment

    Respiration rate detection (breaths per minute)

    Baseline

  • Physical examination - blood pressure

    Blood pressure detection (mmHg)

    Baseline

Study Arms (1)

Patients with a benign prostatic hyperplasia condition

Patients with a benign prostatic hyperplasia condition

Other: Observation of patients with a benign prostatic hyperplasia condition

Interventions

Observation of patients with a benign prostatic hyperplasia condition who have undergone surgery

Patients with a benign prostatic hyperplasia condition

Eligibility Criteria

Age18 Years+
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Subjects suffering from benign prostatic hyperplasia undergoing medical therapy and/or undergoing surgery

You may qualify if:

  • subjects suffering from benign prostatic hyperplasia undergoing medical therapy and/or undergoing surgery
  • subjects \>= 18 years old
  • signature of informed consent

You may not qualify if:

  • subjects \< 18 years
  • presence of mental or physical disability that may prevent the patient from answering the questionnaires.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IRCCS Ospedale San Raffaele

Milan, Lombardy, 20132, Italy

RECRUITING

MeSH Terms

Conditions

Prostatic Hyperplasia

Condition Hierarchy (Ancestors)

Prostatic DiseasesGenital Diseases, MaleGenital DiseasesUrogenital DiseasesMale Urogenital Diseases

Study Officials

  • Andrea Salonia, MD

    IRCCS Ospedale San Raffaele

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Andrea Salonia, MD

CONTACT

Alessia d'Arma, MSc

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

November 21, 2023

First Posted

December 26, 2023

Study Start

December 1, 2014

Primary Completion

December 31, 2024

Study Completion (Estimated)

December 31, 2034

Last Updated

December 26, 2023

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will not share

Locations